SHL – Credit Suisse rates the stock as Underperform

By Broker News | More Articles by Broker News

US Medicare has proposed reductions to fees for 2018. Medicare is seeking public comment until October 23 and final rates will be subsequently published.

The US represents 22% of the company’s revenue in FY17 and Credit Suisse notes around 20% of US revenue is funded by Medicare. The broker’s calculations, assuming price reductions of -9.5% in 2018 and -7.5% in 2019, results in a downgrade to net profit estimates of -3% over the forecasts.

Target is reduced to $21.40 from $22.40. Underperform retained.

Sector: Health Care Equipment & Services. 

Target price is $21.40.Current Price is $21.42. Difference: ($0.02) – (brackets indicate current price is over target). If SHL meets the Credit Suisse target it will return approximately 0% (excluding dividends, fees and charges – negative figures indicate an expected loss).

Broker News

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →